MMWR Early Release - Vol. 71, March 11, 2022

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

Report on COVID-19 Vaccine Effectiveness among Children and Teens

March 11, 2022

EARLY RELEASE

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

PDF of this report (link)

MMWR Weekly COVID-19 Briefing Podcast: Week of February 28

 

The latest MMWR Weekly COVID-19 Briefing is live. This episode covers three reports, including reports highlighting the safety of COVID-19 vaccine booster doses among teens, effectiveness of the Pfizer-BioNTech COVID-19 vaccine among children and teens and more. Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.